US Orphan Drug Pipeline Analysis:Life Sciences Market Research Reports

Life Sciences Market Research Reports

What drives your body? Explore your exercise, sleep and food data to discover your body on projectaddapp From our sponsors

US Orphan Drug Pipeline Analysis Oct 23rd 2013, 00:00, by swapnil In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry. With close to 30 million people in the US having some kind of rare disease complaints, the increasing activities around the development of orphan drugs only imply that the appropriate … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=121635. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/us-orphan-drug-pipeline-analysis-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions